Cutler Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $14K | Sell |
3,300
-19,500
| -86% | -$2.55M | ﹤0.01% | 1147 |
|
|
2023
Q4 | $16K | Buy |
22,800
+17,085
| +299% | +$1.31M | ﹤0.01% | 2098 |
|
|
2023
Q3 | $120K | Buy |
5,715
+180
| +3% | +$18.5K | 0.01% | 1024 |
|
|
2023
Q2 | $55K | Buy |
5,535
+3,115
| +129% | +$388K | 0.01% | 1237 |
|
|
2023
Q1 | $26K | Sell |
2,420
-24,470
| -91% | -$3.32M | ﹤0.01% | 1765 |
|
|
2022
Q4 | $197K | Buy |
26,890
+20,490
| +320% | +$2.86M | 0.02% | 793 |
|
|
2022
Q3 | $179K | Sell |
6,400
-1,645
| -20% | -$302K | 0.01% | 1021 |
|
|
2022
Q2 | $403K | Buy |
8,045
+2,065
| +35% | +$352K | 0.03% | 619 |
|
|
2022
Q1 | $1.5M | Sell |
5,980
-10,785
| -64% | -$4.07M | 0.08% | 272 |
|
|
2021
Q4 | $3.07M | Buy |
16,765
+9,530
| +132% | +$9.12M | 0.13% | 169 |
|
|
2021
Q3 | $869K | Sell |
7,235
-6,165
| -46% | -$7.58M | 0.04% | 520 |
|
|
2021
Q2 | $816K | Buy |
13,400
+7,480
| +126% | +$10.4M | 0.04% | 540 |
|
|
2021
Q1 | $1.04M | Buy |
5,920
+2,105
| +55% | +$4.93M | 0.05% | 423 |
|
|
2020
Q4 | $221K | Sell |
3,815
-3,280
| -46% | -$5.23M | 0.01% | 1029 |
|
|
2020
Q3 | $294K | Buy |
7,095
+3,590
| +102% | +$4.12M | 0.02% | 749 |
|
|
2020
Q2 | $166K | Buy |
3,505
+1,915
| +120% | +$1.66M | 0.01% | 978 |
|
|
2020
Q1 | $351K | Sell |
1,590
-2,595
| -62% | -$2.36M | 0.02% | 688 |
|
|
2019
Q4 | $301K | Sell |
4,185
-12,685
| -75% | -$11.4M | 0.02% | 645 |
|
|
2019
Q3 | $1.15M | Buy |
16,870
+15,000
| +802% | +$12.5M | 0.1% | 169 |
|
|
2019
Q2 | $147K | Sell |
1,870
-11,325
| -86% | -$11M | 0.01% | 882 |
|
|
2019
Q1 | $324K | Buy |
13,195
+12,635
| +2,256% | +$13.1M | 0.03% | 454 |
|
|
2018
Q4 | $305K | Buy |
560
+155
| +38% | +$162K | 0.03% | 473 |
|
|
2018
Q3 | $155K | Buy |
405
+25
| +7% | +$49.1K | 0.01% | 959 |
|
|
2018
Q2 | $179K | Sell |
380
-1,070
| -74% | -$1.88M | 0.01% | 828 |
|
|
2018
Q1 | $429K | Buy |
1,450
+150
| +12% | +$279K | 0.04% | 465 |
|
|
2017
Q4 | $57K | Sell |
1,300
-720
| -36% | -$1.1M | ﹤0.01% | 1766 |
|
|
2017
Q3 | $75K | Sell |
2,020
-5,180
| -72% | -$7.19M | ﹤0.01% | 1899 |
|
|
2017
Q2 | $250K | Buy |
7,200
+2,590
| +56% | +$2.61M | 0.01% | 1115 |
|
|
2017
Q1 | $314K | Sell |
4,610
-2,260
| -33% | -$2.01M | 0.01% | 885 |
|
|
2016
Q4 | $807K | Buy |
6,870
+5,265
| +328% | +$3.95M | 0.03% | 484 |
|
|
2016
Q3 | $105K | Sell |
1,605
-360
| -18% | -$297K | ﹤0.01% | 1763 |
|
|
2016
Q2 | $107K | Buy |
1,965
+80
| +4% | +$50.1K | 0.01% | 1628 |
|
|
2016
Q1 | $92K | Buy |
1,885
+1,819
| +2,756% | +$1.15M | 0.01% | 1694 |
|
|
2015
Q4 | $21K | Buy |
+66
| New | +$107K | ﹤0.01% | 3372 |
|
Other funds holding LABU
TAA
TI
TRCT
GS
Cutler Group's LABU Position: Q1 2024 in Review
Cutler Group reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 99% in Q1 2024, selling an estimated $913K and leaving 66 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.
Cutler Group first reported a position in LABU in Q4 2015 and has held it in 26 quarters since. The position peaked at $5.7M in Q4 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.
- Cutler Group held 66 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $8K as of Q1 2024.
- Cutler Group sold 6,995 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $913K.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1377 holding.
- Cutler Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and has held it in 26 quarters since.
- Cutler Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.7M in Q4 2021.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.